{"id":"mk0777","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T02:21:59.527Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T11:07:32.496250+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT00543920","phase":"PHASE2","title":"A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2002-08","conditions":"Anxiety Disorders","enrollment":60},{"nctId":"NCT00546624","phase":"PHASE2","title":"GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2002-11","conditions":"Anxiety Disorder","enrollment":38},{"nctId":"NCT00703833","phase":"PHASE2","title":"A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2002-09","conditions":"Generalized Anxiety Disorder","enrollment":51},{"nctId":"NCT00539578","phase":"PHASE2","title":"Treatment of Patients With Anxiety Disorder (0777-022)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2002-09","conditions":"Generalized Anxiety Disorder","enrollment":270},{"nctId":"NCT00505076","phase":"PHASE2","title":"Treatment Study for Cognitive Deficits in Schizophrenia","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2007-07","conditions":"Schizophrenia","enrollment":63},{"nctId":"NCT00129441","phase":"PHASE2","title":"Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2005-08","conditions":"Schizophrenia","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"MK0777","genericName":"MK0777","companyName":"Merck Sharp & Dohme LLC","companyId":"merck-sharp-dohme-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T11:07:32.496250+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}